FDA To Request Authority To Approve Follow-On Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency again seeks user fees to pay for review of generic drug applications and direct-to-consumer TV ads; proposes $984 million budget for human drugs and biologics.
You may also be interested in...
Congress Asks FDA Science Board Subcommittee To Quantify Agency Funding Needs
Panel members are well qualified to make budgetary recommendations, chairwoman Gail Cassell of Lilly tells “The Pink Sheet” DAILY.
Congress Asks FDA Science Board Subcommittee To Quantify Agency Funding Needs
Panel members are well qualified to make budgetary recommendations, chairwoman Gail Cassell of Lilly tells “The Pink Sheet” DAILY.
Insmed Takes Follow-On Biologics Push To The Web
Not enough understanding of debate, says Insmed exec; economic study to come